EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

0.01% Atropine for Myopia Prevention in Pre‐myopia ( AMPP study)

Meinan He iD, Hanru Wang iD, Bei Du, Ding Han, Lin Liu iD, Ziyu Zhang, Shuwei Zhang, Lei Wang, Mengdi Chai, Ruihua Wei iD

Ophthalmic and Physiological Optics · 2025-11 · 45 (7) · 1924-1934

DOI: 10.1111/opo.70018 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Ophthalmic and Physiological Optics, online erschienen am 12.09.2025. Verfasst von Meinan He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Centre for Ocular Disease, Eye Institute and S…. Hauptthemen laut MEDLINE: Atropine, Myopia, Refraction, Ocular. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Tianjin Science and Technology Popularization project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to evaluate the efficacy and safety of 0.01% atropine eye drops in preventing myopia in children with pre‐myopia.

Methods

In this randomised controlled trial (ChiCTR2200055482), children aged 5–12 years with cycloplegic spherical equivalent (SE) between +0.75D and −0.50D were randomised 1:1 to receive either 0.01% atropine (once nightly) or placebo (once nightly). The primary endpoint was the change in SE after 12 months.

Results

Sixty‐four subjects (48.4% female) completed the 12‐month follow‐up (32 per group, mean age, 7.47 ± 1.72 vs. 7.84 ± 1.32 years). After 12 months, the change in SE was significantly smaller in the 0.01% atropine group than in the placebo group (−0.23 ± 0.50D vs. −0.49 ± 0.42D; p = 0.03), representing a 53% reduction in myopia progression. No significant intergroup difference was observed in axial length (AL) change (+0.26 ± 0.16 mm vs. +0.32 ± 0.15 mm; p = 0.13), corresponding to a 19% reduction in AL elongation. The 0.01% atropine group exhibited significantly larger pupil diameters at all time points (all p < 0.05), while safety parameters (e.g., amplitude of accommodation, tear film stability, intraocular pressure) remained comparable between the groups (all p > 0.05).

Conclusion

In 5‐ to 12‐year‐old pre‐myopic children, nightly administration of 0.01% atropine eye drops for 1 year was found to delay myopic shift compared with placebo, and no persistent adverse events were observed. Additionally, the atropine group exhibited less axial elongation than the control group, though this difference was not statistically significant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtropineMyopiaRefraction, OcularHumansChildFemaleOphthalmic SolutionsMaleChild, PreschoolMydriaticsDouble-Blind MethodFollow-Up StudiesTreatment OutcomeAccommodation, OcularDisease ProgressionAxial Length, EyeDose-Response Relationship, Drug

Stichwörter der Autor:innen

atropineaxial lengthpre‐myopiarefraction

Substanzen

AtropineOphthalmic SolutionsMydriatics

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Centre for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin,…

ORCID-Profile: Meinan He, Hanru Wang, Lin Liu, Ruihua Wei

Förderung

  • Tianjin Science and Technology Popularization project

Zitieren

APA

He, M., Wang, H., Du, B., Han, D., Liu, L., Zhang, Z., Zhang, S., Wang, L., Chai, M., & Wei, R. (2025). 0.01% Atropine for Myopia Prevention in Pre‐myopia ( AMPP study). Ophthalmic and Physiological Optics, 45(7), 1924-1934. https://doi.org/10.1111/opo.70018

Vancouver

He M, Wang H, Du B, Han D, Liu L, Zhang Z, et al. 0.01% Atropine for Myopia Prevention in Pre‐myopia ( AMPP study). Ophthalmic and Physiological Optics. 2025;45(7):1924-1934. doi:10.1111/opo.70018

BibTeX
@article{He2025,
  author = {He, Meinan and Wang, Hanru and Du, Bei and Han, Ding and Liu, Lin and Zhang, Ziyu and Zhang, Shuwei and Wang, Lei and Chai, Mengdi and Wei, Ruihua},
  title = {0.01% Atropine for Myopia Prevention in Pre‐myopia ( AMPP study)},
  journal = {Ophthalmic and Physiological Optics},
  year = {2025},
  volume = {45},
  number = {7},
  pages = {1924--1934},
  doi = {10.1111/opo.70018}
}
Kostenlos starten →